Abbott: US baby formula plant linked to national shortage resumes productionon June 4, 2022 at 6:35 pm

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Abbott says it is restarting its plant in Michigan after it was closed because of contamination.

This video can not be played

To play this video you need to enable JavaScript in your browser.

US firm Abbott says it is restarting production at a baby formula plant after its shutdown contributed to a national shortage of the baby food.

The plant in Michigan – one of America’s largest – was closed in February because of contamination.

Coupled with global supply chain issues, the factory’s closure led to acute shortages.

Parents were left scrambling for supplies, seeking formula from food banks, friends and doctor’s offices.

Some turned to social media to try to track down baby milk, while others attempted to make their own substitutes (against medical advice).

The facility has met initial government sanitary requirements for reopening, the company said in a statement.

Abbott said it would initially prioritise the production of its EleCare speciality formulas for babies with severe food allergies and digestive problems.

“We’re also working hard to fulfil the steps necessary to restart production of Similac and other formulas,” Abbott said, referring to its more mainstream products. It plans to ramp up production as quickly as possible “while meeting all requirements”, it said.

The company said it would take about three weeks before new formula from the plant began reaching stores.

Last month, US President Joe Biden invoked the Defense Production Act, a war-time measure, to boost domestic production of formula, and ordered the Pentagon to fly in shipments from overseas.

A bill to alleviate the shortage was also overwhelmingly passed by the House of Representatives.

Other countries have supplied formula to boost supplies during the crisis.

The Abbott plant shut down in February after the death of two babies, and the company issued a product recall amid concerns over bacterial contamination.

Inspectors for the Food and Drug Administration (FDA) say they uncovered a number of anomalies at the plant, including bacterial contamination, leaks in the roof and a lack of basic hygiene.

The company says there is no conclusive evidence linking its products to infant illnesses or deaths.

- Advertisement -

Discover

Sponsor

Latest

Leicester knocked out of Europa League in dramatic finish to groupon December 9, 2021 at 8:30 pm

Leicester City are made to pay for slack defending as hosts Napoli advance in the Europa League at the Foxes' expense.

Hinkley Point C delayed by a year as cost goes up by £3bnon May 20, 2022 at 9:59 am

The revised operating date for the Somerset site is June 2027 and is expected to cost up to £26bn.Image source, EDFThe nuclear power station...

Camilla tests positive for coronaviruson February 14, 2022 at 12:45 pm

The Duchess of Cornwall is now self-isolating, days after Prince Charles tested positive for Covid.Image source, ReutersThe Duchess of Cornwall is self-isolating after testing...

Troubled Derby stun promotion-chasing Bournemouthon November 21, 2021 at 2:45 pm

Tom Lawrence's second-half double helps Derby beat promotion-chasing Bournemouth and end a turbulent week in style.

Common Business Card Shapes and Designs

Common Business Card Shapes and DesignsBusiness cards are little cards bearing private business information about an individual or a business. They are usually...